GlassScriptPhysician profile
Matthew G Rosner
NPI 1104283506
$2,382.72
in general payments reported to CMS, 2019-2025
17 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $204 · 2021: $317 · 2022: $137 · 2023: $449 · 2024: $478 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $405.30 | 2019-2021 | |
| Visioneering Technologies, INC. | $364.38 | 2024-2025 | |
| Alcon Vision LLC | $279.15 | 2021-2025 | Tryptyr, Precision7, Precision 1 |
| Novartis Pharmaceuticals Corporation | $254.11 | 2019-2020 | |
| Carl Zeiss Meditec USA, INC. | $249.51 | 2023-2024 | Humphrey Hfa, Atlas Corneal Topography System |
| Sun Pharmaceutical Industries INC. | $204.71 | 2019-2025 | Cequa |
| Optos, INC. | $153.64 | 2019-2021 | |
| Abbvie INC. | $91.56 | 2022-2024 | Lumigan, Alphagan P, Vuity |
| Aerie Pharmaceuticals, INC. | $90.68 | 2019 | |
| Oyster Point Pharma, INC. | $60.04 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $55.87 | 2019-2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $38.75 | 2019 | |
| Maculogix, INC. | $36.43 | 2021 | |
| Harrow Eye, LLC | $35.73 | 2025 | Vevye |
| Sight Sciences, INC. | $23.12 | 2024 | Tearcare System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $22.32 | 2025 | Iyuzeh |
| Coopervision INC. | $17.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Rosner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.